Showing results (81-90 of 106) with videos related to
Sort By:
Pageof 11
Leukemia|March 10, 2026
Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?Dorothée Selimoglu-Buet, Sylvie Chevret, Valeria Santini, et al.Immunity|April 9, 2013
Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cellsYuting Ma, Sandy Adjemian, Stephen R Mattarollo, et al.Blood|October 26, 2021
Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformationXiaona You, Fabao Liu, Moritz Binder, et al.The Journal of Clinical Investigation|November 15, 2024
CXCL8 secreted by immature granulocytes inhibits WT hematopoiesis in chronic myelomonocytic leukemiaPaul Deschamps, Margaux Wacheux, Axel Gosseye, et al.Cancer Cell|March 16, 2017
ETO2-GLIS2 Hijacks Transcriptional Complexes to Drive Cellular Identity and Self-Renewal in Pediatric Acute Megakaryoblastic LeukemiaCécile Thirant, Cathy Ignacimouttou, Cécile K Lopez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2022
Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO NetworkRaphael Itzykson, Valeria Santini, Sylvain Thepot, et al.Nature Genetics|August 18, 2015
Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignanciesJoseph Saliba, Cécile Saint-Martin, Antonio Di Stefano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell LeukemiaAnouchka P Laurent, Aurélie Siret, Cathy Ignacimouttou, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2025
Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid DisordersDavid Fandrei, Jean Pegliasco, Florence Pasquier, et al.Nature Medicine|July 24, 2023
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trialFernanda Mosele, Elise Deluche, Amelie Lusque, et al.Pageof 11